Subcutaneous use of a fast-acting insulin analog: An alternative treatment for pediatric patients with diabetic ketoacidosis

Diabetes Care

Volumn 28, Issue 8, 2005, Pages 1856-1861

  Della Manna, Thais ^a   Steinmetz, Leandra ^a   Campos, Paula R ^a   Farhat, Sylvia C L ^a   Schvartsman, Cláudio ^a   Kuperman, Hilton ^a   Setian, Nuvarte ^a   Damiani, Durval ^a,b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Apto 9 01415 002 ^*  (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN DERIVATIVE; INSULIN LISPRO;

ADOLESCENT; ARTICLE; CHILD; CLINICAL RESEARCH; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DIABETIC KETOACIDOSIS; DOSE TIME EFFECT RELATION; ECONOMIC ASPECT; FEMALE; GLUCOSE BLOOD LEVEL; HOSPITAL ADMISSION; HUMAN; INSULIN TREATMENT; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MALE; METABOLIC ACIDOSIS; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; VEIN BLOOD FLOW;

BLOOD GLUCOSE; CHILD; DIABETES MELLITUS, TYPE 1; DIABETIC KETOACIDOSIS; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INJECTIONS, SUBCUTANEOUS; INSULIN; MALE; PATIENT COMPLIANCE;

EID: 23044512607     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.28.8.1856     Document Type: Article

References (29)

1. Dunger DB, Sperling MA, Acerini CL, Bonn DJ, Daneman D, Danne TPA, Glaser NS, Hanas R, Hintz RL, Levitsky LL, Savage MO, Tasker RC, Wolsdorf JI, European Society for Pediatric Endocrinology, Lawson Wilkins Pediatric Endocrine Society: European Society for Pediatric Endocrinology/Lawson Wilkins Pediatric Endocrine Society consensus statement on diabetic ketoacidosis in children and adolescents. Pediatrics 113:e133-e140, 2004
2. Neu A, Willasch A, Ehehak S, Hub R, Ranke MB, the DIARY Group Baden-Wuerttemberg: Ketoacidosis at onset of type 1 diabetes mellitus in children: frequency and clinical presentation. Pediatr Diabetes 4:77-81, 2003
3. Daneman D: Diabetes-related mortality: a pediatrician's view. Diabetes Care 24: 801-802, 2001
4. Fisher JN, Shahshahni MN, Kitabchi AE: Diabetic ketoacidosis: low-dose insulin therapy by various routes. N Engl J Med 297:238-241, 1979
5. Travis LB, Kalia A: Diabetic ketoacidosis. In Diabetes Mellitus in Children and Adolescents. 1st ed. Travis LB, Ed. Philadelphia, Saunders, 1987, p. 147-168
6. Kitabchi AE, Ayyagari V, Guerra SM: The efficacy of low dose versus conventional therapy of insulin treatment of diabetic ketoacidosis. Ann Intern Med 84:633-638, 1976
7. Luzi L, Barret EJ, Groop LC, Ferrannini E, DeFronzo RA: Metabolic effects of low-dose insulin therapy on glucose metabolism in diabetic ketoacidosis. Diabetes 37: 1470-1477, 1988
8. Kitabchi AE: Low-dose insulin therapy in diabetic ketoacidosis: fact or fiction? Diabetes Metab Rev 5:337-363, 1989
9. Wagner A, Risse A, Brill HL, Wienhausen-Wilke V, Rottman M, Sondern K, Angelkort B: Therapy of severe diabetic ketoacidosis: zero-mortality under very-low-dose insulin application. Diabetes Care 22:674-677, 1999
10. Edge JA, Matyka K: Acute complications of diabetes. In Childhood and Adolescent Diabetes. Court S, Lamb B, Eds. Chichester, U.K., Wiley, 1997, p. 201-223
11. Rosenbloom AL, Hanas R: Diabetic keto-acidosis (DKA): treatment guidelines. Clin Pediatr 35:261-266, 1996
12. Sperling MA: Diabetes mellitus. In Pediatric Endocrinology. 1st ed. Sperling MA, Ed. Philadelphia, Saunders, 1996, p. 229-263
13. White NH: Diabetic ketoacidosis in children. Endocrinol Metab Clin North Am 29: 657-682, 2000
14. Kitabchi AE, Umpierrez GE, Murphy MB, Barret EJ, Kreisberg RA, Malone JI, Wall BM: Management of hyperglycemic crises in patients with diabetes. Diabetes Care 24:131-153, 2001
15. Carroll MF, Shade DS: Ten pivotal questions about diabetic ketoacidosis. Postgrad Med 110:89-95, 2001
16. Levetan CS, Passaro MD, Jablonski KA, Ratner RE: Effects of physician specialty on outcomes in diabetic ketoacidosis. Diabetes Care 22:1790-1795, 1999
17. Umpierrez GE, Latif K, Stoever J, Cuervo R, Park L, Freire AX, Kitabchi AE: Efficacy of subcutaneous insulin lispro versus continous intravenous regular insulin for the treatment of patients with diabetic ketoacidosis. Am J Med 117:291-296, 2004
18. Laffell L: Ketone bodies: a review of physiology, pathophysiology and application of monitoring to diabetes. Diabetes Metab Res Rev 15:412-426, 1999
19. Harris GD, Fiordolisi I: Physiologic management of diabetic ketoacidemia: a 5-year prospective pediatric experience in 231 episodes. Arch Pediatr Adolesc Med 148:1046-1052, 1994
20. Inward CD, Chambers TL: Fluid management in diabetic ketoacidosis. Arch Dis Child 86:443-444, 2002
21. Lebovitz HE: Diabetic ketoacidosis. Lancet 345:767-772, 1995
22. Finberg L: Why do patients with diabetic ketoacidosis have cerebral swelling, and why does treatment sometimes make it worse? Arch Pediatr Adolesc Med 150:785-786, 1996
23. Silver SM, Clark EC, Schroeder BM, Sterns RH: Pathogenesis of cerebral edema after treatment of diabetic ketoacidosis. Kidney M 51:1237-1244, 1997
24. [erratum in Kidney Int 51:1662, 1997]
25. Muir AB, Quisling RG, Yang MCK, Rosenbloom AL: Cerebral edema in childhood diabetic ketoacidosis: natural history, radiographic findings, and early identification. Diabetes Care 27:1541-1546, 2004
26. Genuth S: Diabetic ketoacidosis and hyperosmolar hyperglycemic nonketotic syndrome in adults. In Therapy for Diabetes Mellitus Related Disorders. 3rd ed. Lebovitz HE, Ed. Alexandria, VA, American Diabetes Association, 1998, p. 83-96
27. DeFronzo R, Matsuda M, Barret EJ: Diabetic ketoacidosis: a combined metabolic-neprologic approach to therapy. Diabetes Rev 2:209-238, 1994
28. Umpierrez GE, Cuervo R, Karabell A, Lauf K, Freire AX, Kitabchi AE: Treatment of diabetic ketoacidosis with subcutaneous insulin aspart. Diabetes Care 27:1873-1878, 2004
29. Adrogué HJ, Barrero J, Garabed E: Salutary effects of modest fluid replacement in the treatment of adults with diabetic ketoacidosis. JAMA 262:2108-2113, 1989